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Selectin-mediated tethering and rolling initiates the multi-step process of leukocyte extravasation which is crucial
for the formation of an inﬂammatory inﬁltrate. We studied the impact of platelets on this process in the skin. Using
intravital microscopy, we analyzed platelet interactions with cutaneous post-capillary venules of mouse ears and
observed an increase in platelet rolling if platelets were activated (41.6  20.2% vs. 13.1  8.5% rolling of resting
platelets). Experiments with P-selectin deﬁcient mice and antibodies blocking either P-selectin, GPIIb/IIIa or GPIb
showed that rolling depends on platelet PSGL-1 and GPIIb/IIIa on one hand, and endothelial P-selectin on the other.
Next, formation of platelet-leukocyte aggregates was demonstrated by simultaneous observation of platelets and
leukocytes in vivo utilizing a newly developed two-color technique. Aggregates increased overall leukocyte rolling
(leukocytes alone: 27.4  11.2%, leukocytes with resting platelets: 25.3  10.2%, leukocytes with activated platelets
38.1  11.8%). To investigate if activated platelets may contribute to the pathogenesis of chronic cutaneous
inﬂammation, platelet P-selectin expression was studied in 8 patients with psoriasis. A correlation between platelet
P-selectin expression and disease severity was established. In summary, we show that activated, not resting,
platelets increase leukocyte rolling in murine skin. This increased rolling is due to the aggregate formation of
platelets with leukocytes. We also provide evidence for a potential role of this mechanism in the pathogenesis of
chronic inﬂammatory skin diseases.
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Migration of leukocytes from the vascular system to sites
of pathogenic exposure is a key event in the process of
inflammation and enables the organism to defend itself
against infectious microorganisms. The complex process of
leukocyte extravasation in response to inflammatory stimuli
involves several well-defined steps (Butcher and Picker,
1996; von Andrian and Mackay, 2000). It is initiated by
short-lived adhesive interactions of endothelial selectins
with leukocyte carbohydrate ligands displayed on glyco-
protein scaffolds. These interactions slow down leukocytes,
which then roll along the endothelium. In addition to their
function in coagulation, platelets are increasingly recog-
nized to be involved in this process, indicating their
importance as effector cells of the immune system. Injury
leads to activation of the coagulation pathways; it also
bears the risk of infection. As a consequence of a trig-
gered coagulation cascade, platelets become activated,
leading to morphological changes, release of pro-inflam-
matory mediators (including platelet factor-4, RANTES, and
cytokines) and a change in surface adhesion molecule
expression (Michelson et al, 1987; Lumadue et al, 1996).
Additionally, platelets may further contribute to
inflammation by mediating leukocyte rolling, as they are
capable of binding to them. These platelet–leukocyte
aggregates have been shown to roll along the endothelium
of murine lymph nodes in a cartwheel-like fashion.
The functional relevance of aggregate formation has
been demonstrated by reconstituting a delayed-type
hypersensitivity reaction (which depends on leukocyte
extravasation) in L-selectin-deficient mice, which are unable
to mount such responses. Rolling of platelet-leukocyte
aggregates in lymph nodes involves platelet P-selectin
binding to leukocyte PSGL-1 on the one hand, and
endothelial PNAd on the other hand (Diacovo et al, 1996,
1998).
Given the role of platelets in leukocyte extravasation
in lymph nodes, we asked whether similar mechanisms
might also be involved in cutaneous inflammation. Here
we show that activated, not resting, platelets are capable
of facilitating leukocyte rolling in cutaneous post-capillary
venules. Compared to lymph nodes however, a different
set of adhesion molecules is involved in the skin compart-
ment. Finally, correlation between platelet activation
and the severity of psoriasis, a chronic inflammatory
skin disease, also suggests a possible role in human
pathology.Abbreviation: PBMC, peripheral blood mononuclear cell
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Results
Platelet rolling in murine skin is inﬂuenced by their state
of activation Initially, we characterized the interaction of
platelets with post-capillary venules in murine skin using
intravital microscopy. When resting platelets were injected
into mice, 13.1%  8.5% of them were slowed down in the
mouse ear and displayed a rolling motion along the
endothelium. In contrast, when platelets were activated by
pre-incubation with TRAP, rolling increased more than 3-fold
to 41.6%  20.2% (po0.001, paired t test, n¼26/8 vessels/
mice). The observed increase was not due to changes in
blood flow (470  189 mm per s vs 490  190 mm per s;
p¼n.s.; paired t test) or to residual TRAP in the platelet
suspension (data not shown).
Platelet rolling in murine skin involves a distinct set of
adhesion molecules different from the lymph node
compartment Activation induces profound changes in
adhesion molecules expressed on the platelet surface,
including upregulation of P-selectin, PSGL-1, and GPIIb/IIIa
as well as a decrease in GPIb expression (Michelson et al,
1987; Frenette et al, 2000; Leytin et al, 2000). To identify
adhesion molecules involved in the rolling of activated
platelets along cutaneous microvessels, resting and acti-
vated platelets were injected in both wild-type and P-
selectin-deficient mice in order to determine if interaction of
platelet PSGL-1 with endothelial P-selectin is involved: in
wild-type mice, 41.6%  20.2% (n¼ 26/8 vessels/mice) of
activated platelets rolled along the endothelium. Rolling was
reduced to 20.4%  14.8% in P-selectin-deficient mice
(po0.001, t test, n¼ 22/8 vessels/P-sel/ mice), indicat-
ing that endothelial P-selectin plays a major role. Activated
platelets in P-selectin-deficient mice, however, still rolled
more readily compared to resting platelets (20.4%  14.8%
vs 6.6%  6.8%, po0.001, paired t test, n¼ 22/8 vessels/
mice). Involvement of endothelial P-selectin in mediating
rolling of activated platelets was confirmed in experiments
using an anti-P-selectin antibody, resulting in a significant
decrease in the rolling of activated platelets (Fig 1a). While a
significant decrease with blockade of endothelial P-selectin
in rolling was seen, it was not complete indicating that other
adhesion molecules are additionally involved.
Platelet GPIIb/IIIa binds via fibrinogen to endothelial
ICAM-1 (Simon et al, 1997; Bombeli et al, 1998), which is
constitutively expressed in murine skin (Goebeler et al,
1990; Nyberg et al, 1999; Peschen et al, 1999). Thus, an
interaction of GPIIb/IIIa with endothelial ICAM-1 is another
likely mechanism mediating the rolling of activated platelets
in murine skin microvessels. Similar to the experiments
using a murine P-selectin antibody, rolling of activated
platelets was significantly decreased when a GPIIb/IIIa
antibody was present in the circulation. Again, no complete
inhibition was observed (Fig 1b).
GPIb is another potential P-selectin ligand expressed
on platelets (Romo et al, 1999). A 50% reduction in GPIb
expression, however, induced by platelet activation is
known to have no significant impact on platelet rolling
in vitro (Michelson et al, 1987; van Zanten et al, 1998). We
confirmed these in vitro findings in our in vivo model by
injecting an anti-GPIb antibody and observing no effect on
platelet rolling (Fig 1c).
Activated platelets form aggregates with leukocytes
in vitro Having established the molecular mechanism for
platelet rolling along cutaneous post-capillary venules, we
now addressed the mechanisms of aggregate formation of
platelets with leukocytes (de Bruijne-Admiraal et al, 1992).
In order to investigate which adhesion molecules are
involved in platelet–leukocyte aggregate formation, freshly
isolated resting or activated platelets were incubated with
PBMC followed by measurement of platelet–PBMC aggre-
gates using flow cytometry. In this in vitro assay, the binding
of activated platelets to PBMC was found to be increased
compared to resting platelets (po0.05, Table I). Addition of
neutralizing antibodies against either P-selectin or PSGL-1
completely blocked the activation-induced binding of
platelets to leukocytes, while a combination of both anti-
bodies showed no further decrease in platelet binding. Thus,
Figure1
Rolling of activated platelets in murine post-capillary venules is
mediated by P-selectin and GPIIb/IIIa. The interaction of (i) activated
(gray bars), (ii) resting (white bars), and (iii) activated platelets (lined
bars) plus (a) anti-murine P-selectin Ab, (b) anti-human GPIIb/IIIa Ab, or
(c) anti-human GPIb Ab was consecutively observed in murine skin
post-capillary venules by intravital microscopy. Injection of either anti-
P-selectin or anti-GPIIb/IIIa Ab resulted in a significant reduction in the
rolling fraction of activated platelets. In contrast, anti-GPIb Ab had no
effect on platelet rolling. Data are displayed as relative rolling fractions,
which refer to the rolling of activated platelets (100%). Data are
presented as mean  SD. n¼11/4 vessels/mice for the group treated
with P-selectin antibody, and n¼ 13/3 and 10/3 for mice treated with
GPIIb/IIIa or GPIbAb, respectively. po0.05, n.s.: not significant.
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the binding of activated platelets to leukocytes is solely
mediated by interaction between P-selectin and PSGL-1. A
blocking antibody for Mac-1 did not alter aggregate forma-
tion (Fig 2 and Table I). An increase of antibody concentra-
tion, for all antibodies used in this study, from 10 mg per mL
to 20 or 40 mg per mL had no additional effect (data not
shown).
Activated, not resting, platelets increase leukocyte
rolling in vivo As activated platelets roll along cutaneous
microvessels in vivo and readily form aggregates with
leukocytes in vitro, we hypothesized that activated platelets
contribute to leukocyte rolling. In order to visualize the
interaction of platelets with PBMC, a two-color intravital
microscopy setup was developed by staining platelets with
the green fluorescent dye CFDA-SE and PBMC with the red
fluorescent dye DiI. PBMC were infused into mice either
alone, or together with resting or activated platelets. In
concordance with our in vitro studies described above, a
3-fold increase in platelet–PBMC aggregate formation was
observed when activated platelets were infused (Table II).
The majority of these aggregates of activated platelets and
PBMC showed a high tendency for rolling, whereas only a
minority of the platelet–PBMC aggregates, formed when
resting platelets were present, showed transition into a
rolling motion (Table II).
The increased platelet–leukocyte aggregate formation
and platelet–leukocyte aggregate rolling observed if acti-
vated platelets were present in the circulation impacted
overall leukocyte rolling. No difference was observed with
regard to leukocyte rolling in the presence of resting
platelets. In contrast, leukocyte rolling increased signifi-
cantly when activated platelets were present. This in-
creased tendency for leukocyte rolling was exclusively
due to the formation of platelet–leukocyte aggregates, as
non-aggregated leukocytes showed no change in rolling
frequency. Overall, about one-third of leukocyte rolling was
due to the rolling of aggregates when activated platelets
were infused (Fig 3). These observations were not influ-
enced by the blood flow since this parameter remained
constant, documented by Vfree (Vfree PBMC: 460  295 mm
per s; Vfree PBMCþ resting platelets: 495  293 mm per s;
Vfree PBMCþ activated platelets: 529  178 mm per s;
p¼n.s., paired test).
Platelet activation correlates with disease severity in
patients with chronic plaque-stage psoriasis Our ob-
servations point toward a possible role of activated platelets
in cutaneous inflammation. Therefore, we studied platelet
activation in eight patients with psoriasis, a chronic inflam-
matory skin disease, by flow cytometry using P-selectin
expression as a marker for activation (Michelson et al, 1987).
As shown in Fig 4, platelet P-selectin expression was
increased in eight of eight patients investigated prior to
initiation of anti-psoriatic therapy. Successful therapy re-
sulted in a decrease in PASI as well as a decrease in platelet
Table I. In vitro activated platelets bind PBMC depending on






Control 22.8  2.9 30.2  5.0 o0.05
Mac-1 22.0  2.6 32.7  4.4 o0.05
P-selectin 15.4  3.4 12.7  2.6 n.s.
PSGL-1 16.9  2.4 15.7  3.0 n.s.
P-selectin
and PSGL-1
15.6  3.4 13.0  2.3 n.s.
PBMC were incubated with either resting or activated platelets in the
presence of antibodies. The percentage of platelet–PBMC aggregates
was assessed by flow cytometry: platelets were identified with an
P-CD41 Ab and the number of aggregates was assessed in a leukocyte
gate. Activation-induced binding of platelets predominantly depended
upon platelet P-selectin and PBMC PSGL-1. p: resting vs activated
platelets; n.s.: not significant. Data are presented as mean  SD from six
experiments.
Figure 2
In vitro activated platelets bind PBMC
depending on platelet P-selectin and
leukocyte PSGL-1. PBMC were incu-
bated with either resting or activated
platelets in the presence of antibodies.
The percentage of platelet–PBMC aggre-
gates was assessed by flow cytometry.
Platelets was identified with an FITC-
CD41 Ab and the number of aggregates
was assessed in a leukocyte gate.
Activation-induced binding of platelets
predominately depended upon platelet
P-selectin and PBMC PSGL-1. One repre-
sentative experiment of six is shown.
Addition of anti-P-selectin or anti-PSGL-1
Ab completely inhibited the activation-
induced binding of platelets to leukocytes.
A combination of the two antibodies had
no additional effect.
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P-selectin expression to a level similar to those measured in
healthy controls (Fig 4). Hypercholesterinemia, known to be
associated with platelet activation (Tailor et al, 2003), could
be excluded as possible interference in our analyses, since
included patients showed normal cholesterol values (184.6 
43.9 mg per dL before and 194.6  32.3 mg per dL after
therapy; p¼n.s.; paired t test). Furthermore, P-selectin
expression was found to be independent off both platelet
count and general inflammation mirrored by the C-reactive
protein (data not shown).
Discussion
Leukocyte extravasation is mediated by adhesion mole-
cules expressed on leukocytes and endothelial cells in a
stepwise process, beginning with rolling of leukocytes along
vessel walls (Butcher and Picker, 1996; von Andrian and
Mackay, 2000). This transition to a rolling motion is initiated
by short-lived interactions between leukocytes and en-
dothelial cells. In addition, at least in lymph nodes, platelets
have been shown to participate in this process by forming
bridges between leukocytes and the endothelium. Aggre-
gates of platelets and leukocytes are formed in the
bloodstream via interactions between platelet P-selectin
and leukocyte PSGL-1, which initiates aggregate rolling on
endothelial PNAd expressed at specialized vessels in the
lymph node (Diacovo et al, 1996, 1998). Here we show that
Table II. In vivo formation of platelet–PBMC aggregates is increased when platelets are activated
PBMC and resting platelets (%) PBMC and activated platelets (%) p (activated vs resting)
Platelet–PMBC aggregates/total PBMC 4.7  4.9 17.9  10.1 o0.001
RF aggregates 18.2  38.6 72.7  26.0 ¼0.004
Rolling aggregates/rolling PBMC 4.6  9.6 32.7  20.4 ¼0.001
Using two-color intravital microscopy, the interaction of platelets and PBMC in the bloodstream as well as the interaction of platelet–PBMC
aggregates with endothelium was observed. The rolling fraction (RF) of aggregates was calculated by dividing rolling aggregates by total observed
aggregates in a vessel. Aggregates of activated platelets with PBMC show a high rolling fraction and constitute one-third of total PBMC rolling. Data are
presented as mean  SD from n¼ 12/5 vessels/mice.
Figure 3
Activated platelets mediate rolling of PBMC in murine skin vessels.
Rolling of PBMC and platelets was simultaneously observed in murine
post-capillary venules using two-color intravital microscopy. In the
same vascular beds, rolling of (i) PBMC, (ii) PBMC with resting platelets,
and (iii) PBMC with activated platelets was consecutively assessed.
Activated platelets increased overall PBMC rolling due to rolling of
platelet–PBMC aggregates. Right column: identical to the column on
the left—the light gray column portion represents rolling of PBMC not
bound to platelets, whereas the dark gray column corresponds to the
rolling of platelet–PBMC aggregates. Data are presented as mean 
SD from n¼ 12/5 vessels/mice.
Figure4
Platelet P-selectin expression is increased in patients with
psoriasis. (a) Severity of psoriasis and (b) platelet P-selectin expres-
sion were evaluated in patients before and after successful therapy
(mean duration of therapy 27.3  5.6 d). Increased platelet P-selectin
expression was observed only in untreated patients, who reached the
levels of healthy controls upon disease remission. (c) Furthermore, the
severity of psoriasis as measured by PASI correlated to platelet P-
selectin expression in patients (r¼ 0.83, po0.001). (d) In healthy
controls, platelet P-selectin expression remained constant over a 4-wk
observation period (n¼ 8 patients and 5 controls).
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platelets are also capable of rolling along cutaneous post-
capillary venules, a phenomenon influenced by their state of
activation.
Activation profoundly alters surface expression patterns
of adhesion molecules on platelets: P-selectin, PSGL-1,
and GPIIb/IIIa are upregulated, whereas GPIb expression
decreases. In lymph nodes, rolling of platelet–leukocyte
aggregates involves platelet P-selectin and leukocyte
PSGL-1 as well as endothelial PNAd (Diacovo et al, 1996,
1998). In contrast, we show that similar, but not identical,
platelet–PBMC aggregates utilize platelet PSGL-1 and
GPIIb/IIIa and endothelial P-selectin to roll along post-
capillary venules in the skin. Involvement of distinct sets of
adhesion molecules in different immunologic compartments
is a prerequisite for the extravasation of specific leukocyte
subsets to different tissues in health and disease (Butcher
and Picker, 1996; von Andrian and Mackay, 2000). These
subsets can be characterized at least in part by their
respective tissue-specific homing receptor, such as the
cutaneous lymphocyte-associated antigen for skin (Picker
et al, 1993). Involvement of platelets as bridging com-
pounds between leukocytes and endothelial cells may
potentially decrease the specificity of leukocyte recircula-
tion. Since platelet–PBMC aggregate rolling in the skin relies
on distinct adhesion molecules, platelet–PBMC aggregates
may also display an ability to home to specific sites.
Rolling of activated platelets along skin microvessels
may impact the inflammatory process: activated platelets
have been shown to increase the expression of endothelial
adhesion molecules such as ICAM-1 and cytokine release
(MCP-1 and IL-8) from endothelial cells, a process involving
IL-1 bound to platelet membranes (Kaplanski et al, 1993;
Gawaz et al, 1998, 2000). Other molecules released upon
platelet activation, such as RANTES or platelet-factor-4, are
chemotactic and can activate leukocytes (Deuel et al, 1981;
Kameyoshi et al, 1992; Serizawa et al, 1996; Weyrich et al,
1996). Moreover, direct delivery of chemokines from
platelets to endothelial cells has been demonstrated (Huo
et al, 2003). Additionally, as shown here, significant
contribution comes from platelet–leukocyte aggregate for-
mation. Blocking P-selectin should therefore interrupt
leukocyte–endothelial and leukocyte–platelet interactions
in the skin and may represent an effective means of treating
inflammation. Indeed, inflammatory responses are dimin-
ished in P-selectin-deficient mice or by the presence of
heparin, an inhibitor of L- and P-selectin (Subramaniam
et al, 1995; Wang et al, 2002). This effect has been attributed
to reduced leukocyte extravasation, which can be inhibited
directly by leukocyte–endothelial interactions or, as sug-
gested by this and previous work (Diacovo et al, 1996,
1998), indirectly by the inhibition of leukocyte–platelet–
endothelial interactions.
The functional relevance of platelets in facilitating
leukocyte rolling in the skin has yet to be established in
human pathology. Evidence for platelet activation, however,
is well established in psoriasis, a chronic inflammatory skin
disease (Berrettini et al, 1985; Hayashi et al, 1985; Vila et al,
1991). Our data on increased platelet P-selectin expression
in patients with psoriasis further support this notion.
Interestingly, a correlation was found between the level of
P-selectin expression by platelets and disease severity mea-
sured by PASI. In seemingly unrelated areas of research,
patients with psoriasis were shown to bear an increased risk
for cardiovascular disease (McDonald et al, 1973, 1978; Ena
et al, 1985; Mallbris et al, 2001). This may well be related to
the activated phenotype of platelets in psoriasis.
We conclude that activated platelets support leukocyte
rolling in skin microvasculature by two independent
mechanisms: (i) rolling of activated platelets along skin
vessels provides an environment of pro-inflammatory
mediators, and (ii) activated platelets bind leukocytes in
the bloodstream, leading to the formation of aggregates
that roll along the endothelium and increase overall
leukocyte rolling (Fig 5). Hence, platelets must be con-
sidered important effector cells of the skin immune system.
Materials and Methods
Platelet isolation Platelets were isolated by drawing blood from
donors through a 21 gauge needle, collected in 3 mL tubes
containing Na-citrate (Sarstedt, Numbrecht, Germany), and im-
mediately spun at 110  g for 15 min at 241C to gain platelet-rich
plasma. Platelets were separated from the plasma proteins by gel
filtration (Hartwig et al, 1991) through a Sepharose 2B (Pharmacia,
Uppsala, Sweden) column. Platelet isolation did not change
P-selectin expression as determined by flow cytometry (data not
shown). Platelets were then activated using 2.5 mM thrombin
receptor activating peptide (TRAP). Activation status was con-
firmed by measuring expression of P-selectin on platelets using
FACS.
Peripheral blood mononuclear cell (PBMC) isolation Human
PBMC were prepared by Ficoll–Hypaque density gradient sedi-
mentation (Pharmacia, Uppsala, Sweden) from buffy coats
obtained from the Department for Transfusion Medicine of the
Johann Wolfgang Goethe-University Frankfurt, and adjusted to
3  107 cell per mL in AIM V cell culture medium (Life
Technologies, Paisley, UK).
Figure5
Interactions of platelets with leukocytes in skin microvasculature.
Activated platelets (1) and leukocytes (2) form platelet–leukocyte
aggregates in the bloodstream. Formation of aggregates depends on
platelet P-selectin and leukocyte PSGL-1 expression (3). Both platelet–
leukocyte aggregates and platelets can interact with endothelial cells
(4) of skin vessels using at least two different pairs of adhesion
molecules: (5) interaction of platelet GPIIb/IIIa with endothelial ICAM-1
via fibrinogen, (6) binding of platelet PSGL-1 to endothelial P-selectin,
and (7) potential binding of platelet P-selectin to endothelial PNAd in
inflamed skin (Lechleitner et al, 1999).
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Antibodies and reagents For in vitro platelet–leukocyte binding
experiments, the following antibodies were used: PE-labeled HIP8
antibody (BD Biosciences, Heidelberg, Germany) to identify
platelet CD41a, 9E1 (R&D Systems, Wiesbaden, Germany)
recognizing CD62P, PL-1 (Immunotech, Hamburg, Germany), a
blocking PSGL-1 Ab and a blocking Mac-1 Ab (clone ICRF44, BD
Biosciences). Corresponding isotype antibodies served as con-
trols. The following antibodies were used for intravital microscopy:
SZ2 (Immunotech) recognizing the human GPIb antigen, anti-
mouse P-selectin Ab (clone RB40.34 from BD Biosciences) and
clone SZ21 (Immunotech), a blocking Ab for human GPIIb/IIIa.
TRAP was purchased from Bachem (Heidelberg, Germany).
In vitro binding of platelets to PBMC Resting or activated
platelets were incubated with isolated PBMC in the presence of
antibody (10 mg per mL) for 15 min at room temperature. After
incubation, PE-labeled anti CD41a Ab (clone HIP8, BD Bio-
sciences) was added for another 15 min to visualize platelets. In
each sample, irrelevant Ab of the appropriate isotype were used as
controls. Finally 500 mL of CellWASH solution (BD Biosciences)
was added and samples were immediately analyzed on a FACScan
(BD Biosciences): PBMC were detected in a gate set on
lymphocyte-sized cells. The number of platelet–PBMC aggregates
was assessed by dividing the red fluorescent cells (PE-labeled
platelets) in the leukocyte gate through the number of all
leukocytes.
Fluorescent labeling of PBMC and platelets For intravital
microscopy experiments, PBMC (3  107 cell per mL) were
incubated with 2.5 mM Vybrant DiI cell-labeling solution (Molecular
Probes, Eugene, Oregon) for 20 min at 371C in the dark. Treated
cells were washed, resuspended to 3  107 cell per mL in AIM V
cell culture medium, and used immediately. For single-color
fluorescent experiments, platelets were stained with BCECF (0.2
mM, 30 min at RT, Molecular Probes). For two-color fluorescent
intravital microscopy, isolated platelets were incubated with 10 mM
CFDA-SE (Molecular Probes) for 30 min at 371C in the dark.
Platelets were separated from excess dye by gel filtration as
mentioned above.
Mice Male C57BL/6 mice aged 6–10 wk were obtained from
Charles River (Sulzfeld, Germany). P-selectin-deficient mice were
originally obtained from Jackson Laboratories (Bar Harbor, Maine),
and are now bred in our facility. All animal experiments were
approved by the governmental administration of Hessen (Darm-
stadt, Germany).
Intravital microscopy Intravital microscopy of mouse ears was
performed in order to observe the rolling of human leukocytes and
platelets whose selectins and ligands efficiently interact across this
species barrier (Robert et al, 1999). Additionally, E- and P-selectin,
which can be detected in psoriatic skin lesions and other chronic-
inflammatory skin diseases (e.g., atopic dermatitis and contact
dermatitis (Barker, 1995)), are constitutively expressed in normal
mouse skin (Weninger et al, 2000). Mice were anesthetized by
intraperitoneal injection of Ketamin (Schwabe-Curamed, Karlsruhe,
Germany) and Rompun (Bayer, Leverkusen, Germany), and placed
on a homothermic blanket. The right carotid artery was prepared
microsurgically and a catheter was inserted downstream into this
vessel for injection of cells and antibodies. The left ear of the
mouse was gently placed on a microscope slide, covered with
glycerin, and a coverslip. For simultaneous observation of two
different cell types in the same vascular bed, a novel two-color
intravital microscopy system was developed based on a previously
described setup (Schon et al, 2002). Vascular architecture and
labeled cells were visualized during their passage through vessels
under fluorescent epi-illumination using a multiband-filter system
(XF 53, Omega Optical, Brattleboro, Vermont). Continuous video
recordings of the microcirculation were obtained using a 1/300 DSP
3-CCD camera (DXC-390, Sony, Ko¨ln, Germany) mounted on a
modified (Baatz et al, 1995) Zeiss microscope (Axiotech Vario 100
HD, Zeiss, Germany) equipped with a  10 saltwater immersion
objective (Nikon, Du¨sseldorf, Germany). Images were stored on
tape using a Panasonic AG 7355 videocassette recorder. Subse-
quently, cells and/or antibodies (4 mg per kg b.w.) were injected.
With the exception of antibodies, the order of injection was
selected randomly. Cell behavior in individual vessel segments was
determined by playback of video tapes. Cells were considered
non-interacting when they moved at the velocity of the mean blood
flow (Vfree), whereas detectable lower velocities were defined as
rolling. To determine Vfree, the mean velocity of at least 15 non-
interacting cells was calculated for each vessel.
Patients For analysis of platelet P-selectin expression, blood from
eight patients with psoriasis and five healthy controls was collected
in 3 mL tubes containing Na-citrate (Sarstedt, Nu¨mbrecht,
Germany) after informed consent was obtained. Thereafter, blood
was incubated with FITC-labeled anti CD62P antibody (clone AK4)
to stain for P-selectin and PE-labeled anti-CD41a antibody (clone
HIP8, both from BD Biosciences, Heidelberg, Germany) for
identification of platelets according to the manufacturer’s instruc-
tions. After incubation for 15 min at room temperature, samples
were diluted with CellWASH solution (BD Biosciences) and
analyzed on FACScan (BD Biosciences). Severity of psoriasis
was assessed using the ‘‘psoriasis area and severity index’’ (PASI)
(Papp et al, 2003). Patients were treated independently from this
study. The mean duration of treatment was 27  5 days. Experi-
ments were approved by the ethics committee of the J.W. Goethe
University (Frankfurt, Germany) and were conducted in accor-
dance with the Declaration of Helsinki.
Statistical analysis Data are presented as mean  standard
deviation if not otherwise indicated. Statistics were performed
using SigmaStat (SPSS, Chicago, Illinois). The following tests were
used to calculate statistical significance: Pearson product moment
correlation to test for correlation, one-way ANOVA to test for
differences in rolling, and the paired t test to test for differences in
platelet P-selectin expression before and after therapy.
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